Medical Devices & Consumables
Global Fibrous Demineralized Bone Matrix (DBM) Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 606251
- Pages: 158
- Figures: 157
- Views: 1
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Fibrous Demineralized Bone Matrix (DBM) market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Medtronic
J &J (DePuy Synthes)
Zimmer Biomet
Stryker
SeaSpine
Wright Medical
Straumann
Xtant Medical
Hans Biomed
Arthrex
VIVEX Biologics
Segment by Type
Gel
Putty
Others
Segment by Application
Dental Surgery
Spine Surgery
Trauma Surgery
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Fibrous Demineralized Bone Matrix (DBM) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Fibrous Demineralized Bone Matrix (DBM) market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Medtronic
J &J (DePuy Synthes)
Zimmer Biomet
Stryker
SeaSpine
Wright Medical
Straumann
Xtant Medical
Hans Biomed
Arthrex
VIVEX Biologics
Segment by Type
Gel
Putty
Others
Segment by Application
Dental Surgery
Spine Surgery
Trauma Surgery
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Fibrous Demineralized Bone Matrix (DBM) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Fibrous Demineralized Bone Matrix (DBM): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Fibrous Demineralized Bone Matrix (DBM) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Gel
1.2.3 Putty
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Fibrous Demineralized Bone Matrix (DBM) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Dental Surgery
1.3.3 Spine Surgery
1.3.4 Trauma Surgery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Fibrous Demineralized Bone Matrix (DBM) Revenue Estimates and Forecasts 2020-2031
2.2 Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Fibrous Demineralized Bone Matrix (DBM) Sales Estimates and Forecasts 2020-2031
2.4 Global Fibrous Demineralized Bone Matrix (DBM) Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Fibrous Demineralized Bone Matrix (DBM) Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Fibrous Demineralized Bone Matrix (DBM) Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Gel Market Size by Manufacturers
3.5.2 Putty Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Fibrous Demineralized Bone Matrix (DBM) Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Fibrous Demineralized Bone Matrix (DBM) Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Fibrous Demineralized Bone Matrix (DBM) Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Fibrous Demineralized Bone Matrix (DBM) Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Type (2020-2031)
6.4 North America Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Fibrous Demineralized Bone Matrix (DBM) Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Type (2020-2031)
7.4 Europe Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Fibrous Demineralized Bone Matrix (DBM) Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Type (2020-2031)
9.4 Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Fibrous Demineralized Bone Matrix (DBM) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.1.4 Medtronic Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Fibrous Demineralized Bone Matrix (DBM) Sales by Product in 2024
11.1.6 Medtronic Fibrous Demineralized Bone Matrix (DBM) Sales by Application in 2024
11.1.7 Medtronic Fibrous Demineralized Bone Matrix (DBM) Sales by Geographic Area in 2024
11.1.8 Medtronic Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 J &J (DePuy Synthes)
11.2.1 J &J (DePuy Synthes) Corporation Information
11.2.2 J &J (DePuy Synthes) Business Overview
11.2.3 J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.2.4 J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) Sales by Product in 2024
11.2.6 J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) Sales by Application in 2024
11.2.7 J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) Sales by Geographic Area in 2024
11.2.8 J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
11.2.9 J &J (DePuy Synthes) Recent Developments
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Corporation Information
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.3.4 Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) Sales by Product in 2024
11.3.6 Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) Sales by Application in 2024
11.3.7 Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) Sales by Geographic Area in 2024
11.3.8 Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
11.3.9 Zimmer Biomet Recent Developments
11.4 Stryker
11.4.1 Stryker Corporation Information
11.4.2 Stryker Business Overview
11.4.3 Stryker Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.4.4 Stryker Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Stryker Fibrous Demineralized Bone Matrix (DBM) Sales by Product in 2024
11.4.6 Stryker Fibrous Demineralized Bone Matrix (DBM) Sales by Application in 2024
11.4.7 Stryker Fibrous Demineralized Bone Matrix (DBM) Sales by Geographic Area in 2024
11.4.8 Stryker Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
11.4.9 Stryker Recent Developments
11.5 SeaSpine
11.5.1 SeaSpine Corporation Information
11.5.2 SeaSpine Business Overview
11.5.3 SeaSpine Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.5.4 SeaSpine Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 SeaSpine Fibrous Demineralized Bone Matrix (DBM) Sales by Product in 2024
11.5.6 SeaSpine Fibrous Demineralized Bone Matrix (DBM) Sales by Application in 2024
11.5.7 SeaSpine Fibrous Demineralized Bone Matrix (DBM) Sales by Geographic Area in 2024
11.5.8 SeaSpine Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
11.5.9 SeaSpine Recent Developments
11.6 Wright Medical
11.6.1 Wright Medical Corporation Information
11.6.2 Wright Medical Business Overview
11.6.3 Wright Medical Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.6.4 Wright Medical Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Wright Medical Recent Developments
11.7 Straumann
11.7.1 Straumann Corporation Information
11.7.2 Straumann Business Overview
11.7.3 Straumann Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.7.4 Straumann Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Straumann Recent Developments
11.8 Xtant Medical
11.8.1 Xtant Medical Corporation Information
11.8.2 Xtant Medical Business Overview
11.8.3 Xtant Medical Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.8.4 Xtant Medical Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Xtant Medical Recent Developments
11.9 Hans Biomed
11.9.1 Hans Biomed Corporation Information
11.9.2 Hans Biomed Business Overview
11.9.3 Hans Biomed Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.9.4 Hans Biomed Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Hans Biomed Recent Developments
11.10 Arthrex
11.10.1 Arthrex Corporation Information
11.10.2 Arthrex Business Overview
11.10.3 Arthrex Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.10.4 Arthrex Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Arthrex Recent Developments
11.11 VIVEX Biologics
11.11.1 VIVEX Biologics Corporation Information
11.11.2 VIVEX Biologics Business Overview
11.11.3 VIVEX Biologics Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.11.4 VIVEX Biologics Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 VIVEX Biologics Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Fibrous Demineralized Bone Matrix (DBM) Industry Chain
12.2 Fibrous Demineralized Bone Matrix (DBM) Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Fibrous Demineralized Bone Matrix (DBM) Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Fibrous Demineralized Bone Matrix (DBM) Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Fibrous Demineralized Bone Matrix (DBM) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Fibrous Demineralized Bone Matrix (DBM) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Fibrous Demineralized Bone Matrix (DBM): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Fibrous Demineralized Bone Matrix (DBM) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Gel
1.2.3 Putty
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Fibrous Demineralized Bone Matrix (DBM) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Dental Surgery
1.3.3 Spine Surgery
1.3.4 Trauma Surgery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Fibrous Demineralized Bone Matrix (DBM) Revenue Estimates and Forecasts 2020-2031
2.2 Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Fibrous Demineralized Bone Matrix (DBM) Sales Estimates and Forecasts 2020-2031
2.4 Global Fibrous Demineralized Bone Matrix (DBM) Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Fibrous Demineralized Bone Matrix (DBM) Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Fibrous Demineralized Bone Matrix (DBM) Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Gel Market Size by Manufacturers
3.5.2 Putty Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Fibrous Demineralized Bone Matrix (DBM) Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Fibrous Demineralized Bone Matrix (DBM) Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Fibrous Demineralized Bone Matrix (DBM) Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Fibrous Demineralized Bone Matrix (DBM) Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Type (2020-2031)
6.4 North America Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Fibrous Demineralized Bone Matrix (DBM) Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Type (2020-2031)
7.4 Europe Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Fibrous Demineralized Bone Matrix (DBM) Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Type (2020-2031)
9.4 Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Fibrous Demineralized Bone Matrix (DBM) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.1.4 Medtronic Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Fibrous Demineralized Bone Matrix (DBM) Sales by Product in 2024
11.1.6 Medtronic Fibrous Demineralized Bone Matrix (DBM) Sales by Application in 2024
11.1.7 Medtronic Fibrous Demineralized Bone Matrix (DBM) Sales by Geographic Area in 2024
11.1.8 Medtronic Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 J &J (DePuy Synthes)
11.2.1 J &J (DePuy Synthes) Corporation Information
11.2.2 J &J (DePuy Synthes) Business Overview
11.2.3 J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.2.4 J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) Sales by Product in 2024
11.2.6 J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) Sales by Application in 2024
11.2.7 J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) Sales by Geographic Area in 2024
11.2.8 J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
11.2.9 J &J (DePuy Synthes) Recent Developments
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Corporation Information
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.3.4 Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) Sales by Product in 2024
11.3.6 Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) Sales by Application in 2024
11.3.7 Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) Sales by Geographic Area in 2024
11.3.8 Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
11.3.9 Zimmer Biomet Recent Developments
11.4 Stryker
11.4.1 Stryker Corporation Information
11.4.2 Stryker Business Overview
11.4.3 Stryker Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.4.4 Stryker Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Stryker Fibrous Demineralized Bone Matrix (DBM) Sales by Product in 2024
11.4.6 Stryker Fibrous Demineralized Bone Matrix (DBM) Sales by Application in 2024
11.4.7 Stryker Fibrous Demineralized Bone Matrix (DBM) Sales by Geographic Area in 2024
11.4.8 Stryker Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
11.4.9 Stryker Recent Developments
11.5 SeaSpine
11.5.1 SeaSpine Corporation Information
11.5.2 SeaSpine Business Overview
11.5.3 SeaSpine Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.5.4 SeaSpine Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 SeaSpine Fibrous Demineralized Bone Matrix (DBM) Sales by Product in 2024
11.5.6 SeaSpine Fibrous Demineralized Bone Matrix (DBM) Sales by Application in 2024
11.5.7 SeaSpine Fibrous Demineralized Bone Matrix (DBM) Sales by Geographic Area in 2024
11.5.8 SeaSpine Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
11.5.9 SeaSpine Recent Developments
11.6 Wright Medical
11.6.1 Wright Medical Corporation Information
11.6.2 Wright Medical Business Overview
11.6.3 Wright Medical Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.6.4 Wright Medical Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Wright Medical Recent Developments
11.7 Straumann
11.7.1 Straumann Corporation Information
11.7.2 Straumann Business Overview
11.7.3 Straumann Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.7.4 Straumann Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Straumann Recent Developments
11.8 Xtant Medical
11.8.1 Xtant Medical Corporation Information
11.8.2 Xtant Medical Business Overview
11.8.3 Xtant Medical Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.8.4 Xtant Medical Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Xtant Medical Recent Developments
11.9 Hans Biomed
11.9.1 Hans Biomed Corporation Information
11.9.2 Hans Biomed Business Overview
11.9.3 Hans Biomed Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.9.4 Hans Biomed Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Hans Biomed Recent Developments
11.10 Arthrex
11.10.1 Arthrex Corporation Information
11.10.2 Arthrex Business Overview
11.10.3 Arthrex Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.10.4 Arthrex Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Arthrex Recent Developments
11.11 VIVEX Biologics
11.11.1 VIVEX Biologics Corporation Information
11.11.2 VIVEX Biologics Business Overview
11.11.3 VIVEX Biologics Fibrous Demineralized Bone Matrix (DBM) Product Models, Descriptions and Specifications
11.11.4 VIVEX Biologics Fibrous Demineralized Bone Matrix (DBM) Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 VIVEX Biologics Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Fibrous Demineralized Bone Matrix (DBM) Industry Chain
12.2 Fibrous Demineralized Bone Matrix (DBM) Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Fibrous Demineralized Bone Matrix (DBM) Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Fibrous Demineralized Bone Matrix (DBM) Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Fibrous Demineralized Bone Matrix (DBM) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Fibrous Demineralized Bone Matrix (DBM) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Fibrous Demineralized Bone Matrix (DBM) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Fibrous Demineralized Bone Matrix (DBM) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Fibrous Demineralized Bone Matrix (DBM) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Region (2020-2025) & (K Units)
Table 8. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Fibrous Demineralized Bone Matrix (DBM) Sales Share by Manufacturers (2020-2025)
Table 12. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Fibrous Demineralized Bone Matrix (DBM) Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Fibrous Demineralized Bone Matrix (DBM) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibrous Demineralized Bone Matrix (DBM) as of 2024)
Table 16. Global Fibrous Demineralized Bone Matrix (DBM) Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Fibrous Demineralized Bone Matrix (DBM) Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Fibrous Demineralized Bone Matrix (DBM) Manufacturing Base and Headquarters
Table 19. Global Fibrous Demineralized Bone Matrix (DBM) Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Type (2020-2025) & (K Units)
Table 23. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Type (2026-2031) & (K Units)
Table 24. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Fibrous Demineralized Bone Matrix (DBM) ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Application (2020-2025) & (K Units)
Table 29. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Application (2026-2031) & (K Units)
Table 30. Fibrous Demineralized Bone Matrix (DBM) High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Fibrous Demineralized Bone Matrix (DBM) ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Fibrous Demineralized Bone Matrix (DBM) Growth Accelerators and Market Barriers
Table 37. North America Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Fibrous Demineralized Bone Matrix (DBM) Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Fibrous Demineralized Bone Matrix (DBM) Growth Accelerators and Market Barriers
Table 40. Europe Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Fibrous Demineralized Bone Matrix (DBM) Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Growth Accelerators and Market Barriers
Table 45. Southeast Asia Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Fibrous Demineralized Bone Matrix (DBM) Investment Opportunities and Key Challenges
Table 47. Central and South America Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Medtronic Corporation Information
Table 51. Medtronic Description and Major Businesses
Table 52. Medtronic Product Models, Descriptions and Specifications
Table 53. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Medtronic Sales Value Proportion by Product in 2024
Table 55. Medtronic Sales Value Proportion by Application in 2024
Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 57. Medtronic Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
Table 58. Medtronic Recent Developments
Table 59. J &J (DePuy Synthes) Corporation Information
Table 60. J &J (DePuy Synthes) Description and Major Businesses
Table 61. J &J (DePuy Synthes) Product Models, Descriptions and Specifications
Table 62. J &J (DePuy Synthes) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. J &J (DePuy Synthes) Sales Value Proportion by Product in 2024
Table 64. J &J (DePuy Synthes) Sales Value Proportion by Application in 2024
Table 65. J &J (DePuy Synthes) Sales Value Proportion by Geographic Area in 2024
Table 66. J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
Table 67. J &J (DePuy Synthes) Recent Developments
Table 68. Zimmer Biomet Corporation Information
Table 69. Zimmer Biomet Description and Major Businesses
Table 70. Zimmer Biomet Product Models, Descriptions and Specifications
Table 71. Zimmer Biomet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Zimmer Biomet Sales Value Proportion by Product in 2024
Table 73. Zimmer Biomet Sales Value Proportion by Application in 2024
Table 74. Zimmer Biomet Sales Value Proportion by Geographic Area in 2024
Table 75. Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
Table 76. Zimmer Biomet Recent Developments
Table 77. Stryker Corporation Information
Table 78. Stryker Description and Major Businesses
Table 79. Stryker Product Models, Descriptions and Specifications
Table 80. Stryker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Stryker Sales Value Proportion by Product in 2024
Table 82. Stryker Sales Value Proportion by Application in 2024
Table 83. Stryker Sales Value Proportion by Geographic Area in 2024
Table 84. Stryker Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
Table 85. Stryker Recent Developments
Table 86. SeaSpine Corporation Information
Table 87. SeaSpine Description and Major Businesses
Table 88. SeaSpine Product Models, Descriptions and Specifications
Table 89. SeaSpine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. SeaSpine Sales Value Proportion by Product in 2024
Table 91. SeaSpine Sales Value Proportion by Application in 2024
Table 92. SeaSpine Sales Value Proportion by Geographic Area in 2024
Table 93. SeaSpine Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
Table 94. SeaSpine Recent Developments
Table 95. Wright Medical Corporation Information
Table 96. Wright Medical Description and Major Businesses
Table 97. Wright Medical Product Models, Descriptions and Specifications
Table 98. Wright Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Wright Medical Recent Developments
Table 100. Straumann Corporation Information
Table 101. Straumann Description and Major Businesses
Table 102. Straumann Product Models, Descriptions and Specifications
Table 103. Straumann Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Straumann Recent Developments
Table 105. Xtant Medical Corporation Information
Table 106. Xtant Medical Description and Major Businesses
Table 107. Xtant Medical Product Models, Descriptions and Specifications
Table 108. Xtant Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Xtant Medical Recent Developments
Table 110. Hans Biomed Corporation Information
Table 111. Hans Biomed Description and Major Businesses
Table 112. Hans Biomed Product Models, Descriptions and Specifications
Table 113. Hans Biomed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Hans Biomed Recent Developments
Table 115. Arthrex Corporation Information
Table 116. Arthrex Description and Major Businesses
Table 117. Arthrex Product Models, Descriptions and Specifications
Table 118. Arthrex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Arthrex Recent Developments
Table 120. VIVEX Biologics Corporation Information
Table 121. VIVEX Biologics Description and Major Businesses
Table 122. VIVEX Biologics Product Models, Descriptions and Specifications
Table 123. VIVEX Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. VIVEX Biologics Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Fibrous Demineralized Bone Matrix (DBM) Product Picture
Figure 2. Global Fibrous Demineralized Bone Matrix (DBM) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Gel Product Picture
Figure 4. Putty Product Picture
Figure 5. Others Product Picture
Figure 6. Global Fibrous Demineralized Bone Matrix (DBM) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Dental Surgery
Figure 8. Spine Surgery
Figure 9. Trauma Surgery
Figure 10. Fibrous Demineralized Bone Matrix (DBM) Report Years Considered
Figure 11. Global Fibrous Demineralized Bone Matrix (DBM) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 13. Global Fibrous Demineralized Bone Matrix (DBM) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Fibrous Demineralized Bone Matrix (DBM) Revenue Market Share by Region (2020-2031)
Figure 15. Global Fibrous Demineralized Bone Matrix (DBM) Sales (2020-2031) & (K Units)
Figure 16. Global Fibrous Demineralized Bone Matrix (DBM) Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Fibrous Demineralized Bone Matrix (DBM) Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Fibrous Demineralized Bone Matrix (DBM) Sales Volume Market Share in 2024
Figure 19. Global Fibrous Demineralized Bone Matrix (DBM) Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Gel Revenue Market Share by Manufacturer in 2024
Figure 22. Putty Revenue Market Share by Manufacturer in 2024
Figure 23. Others Revenue Market Share by Manufacturer in 2024
Figure 24. Global Fibrous Demineralized Bone Matrix (DBM) Sales Market Share by Type (2020-2031)
Figure 25. Global Fibrous Demineralized Bone Matrix (DBM) Revenue Market Share by Type (2020-2031)
Figure 26. Global Fibrous Demineralized Bone Matrix (DBM) Sales Market Share by Application (2020-2031)
Figure 27. Global Fibrous Demineralized Bone Matrix (DBM) Revenue Market Share by Application (2020-2031)
Figure 28. North America Fibrous Demineralized Bone Matrix (DBM) Sales YoY (2020-2031) & (K Units)
Figure 29. North America Fibrous Demineralized Bone Matrix (DBM) Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) in 2024
Figure 31. North America Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Fibrous Demineralized Bone Matrix (DBM) Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Fibrous Demineralized Bone Matrix (DBM) Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) in 2024
Figure 41. Europe Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 46. France Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 61. India Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Fibrous Demineralized Bone Matrix (DBM) Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Fibrous Demineralized Bone Matrix (DBM) Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2025) & (US$ Million)
Figure 82. Fibrous Demineralized Bone Matrix (DBM) Industry Chain Mapping
Figure 83. Regional Fibrous Demineralized Bone Matrix (DBM) Manufacturing Base Distribution (%)
Figure 84. Global Fibrous Demineralized Bone Matrix (DBM) Production Market Share by Region (2020-2031)
Figure 85. Fibrous Demineralized Bone Matrix (DBM) Production Process
Figure 86. Regional Fibrous Demineralized Bone Matrix (DBM) Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Table 1. Global Fibrous Demineralized Bone Matrix (DBM) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Fibrous Demineralized Bone Matrix (DBM) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Fibrous Demineralized Bone Matrix (DBM) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Region (2020-2025) & (K Units)
Table 8. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Fibrous Demineralized Bone Matrix (DBM) Sales Share by Manufacturers (2020-2025)
Table 12. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Fibrous Demineralized Bone Matrix (DBM) Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Fibrous Demineralized Bone Matrix (DBM) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibrous Demineralized Bone Matrix (DBM) as of 2024)
Table 16. Global Fibrous Demineralized Bone Matrix (DBM) Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Fibrous Demineralized Bone Matrix (DBM) Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Fibrous Demineralized Bone Matrix (DBM) Manufacturing Base and Headquarters
Table 19. Global Fibrous Demineralized Bone Matrix (DBM) Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Type (2020-2025) & (K Units)
Table 23. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Type (2026-2031) & (K Units)
Table 24. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Fibrous Demineralized Bone Matrix (DBM) ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Application (2020-2025) & (K Units)
Table 29. Global Fibrous Demineralized Bone Matrix (DBM) Sales by Application (2026-2031) & (K Units)
Table 30. Fibrous Demineralized Bone Matrix (DBM) High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Fibrous Demineralized Bone Matrix (DBM) Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Fibrous Demineralized Bone Matrix (DBM) ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Fibrous Demineralized Bone Matrix (DBM) Growth Accelerators and Market Barriers
Table 37. North America Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Fibrous Demineralized Bone Matrix (DBM) Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Fibrous Demineralized Bone Matrix (DBM) Growth Accelerators and Market Barriers
Table 40. Europe Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Fibrous Demineralized Bone Matrix (DBM) Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Growth Accelerators and Market Barriers
Table 45. Southeast Asia Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Fibrous Demineralized Bone Matrix (DBM) Investment Opportunities and Key Challenges
Table 47. Central and South America Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Medtronic Corporation Information
Table 51. Medtronic Description and Major Businesses
Table 52. Medtronic Product Models, Descriptions and Specifications
Table 53. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Medtronic Sales Value Proportion by Product in 2024
Table 55. Medtronic Sales Value Proportion by Application in 2024
Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 57. Medtronic Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
Table 58. Medtronic Recent Developments
Table 59. J &J (DePuy Synthes) Corporation Information
Table 60. J &J (DePuy Synthes) Description and Major Businesses
Table 61. J &J (DePuy Synthes) Product Models, Descriptions and Specifications
Table 62. J &J (DePuy Synthes) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. J &J (DePuy Synthes) Sales Value Proportion by Product in 2024
Table 64. J &J (DePuy Synthes) Sales Value Proportion by Application in 2024
Table 65. J &J (DePuy Synthes) Sales Value Proportion by Geographic Area in 2024
Table 66. J &J (DePuy Synthes) Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
Table 67. J &J (DePuy Synthes) Recent Developments
Table 68. Zimmer Biomet Corporation Information
Table 69. Zimmer Biomet Description and Major Businesses
Table 70. Zimmer Biomet Product Models, Descriptions and Specifications
Table 71. Zimmer Biomet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Zimmer Biomet Sales Value Proportion by Product in 2024
Table 73. Zimmer Biomet Sales Value Proportion by Application in 2024
Table 74. Zimmer Biomet Sales Value Proportion by Geographic Area in 2024
Table 75. Zimmer Biomet Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
Table 76. Zimmer Biomet Recent Developments
Table 77. Stryker Corporation Information
Table 78. Stryker Description and Major Businesses
Table 79. Stryker Product Models, Descriptions and Specifications
Table 80. Stryker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Stryker Sales Value Proportion by Product in 2024
Table 82. Stryker Sales Value Proportion by Application in 2024
Table 83. Stryker Sales Value Proportion by Geographic Area in 2024
Table 84. Stryker Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
Table 85. Stryker Recent Developments
Table 86. SeaSpine Corporation Information
Table 87. SeaSpine Description and Major Businesses
Table 88. SeaSpine Product Models, Descriptions and Specifications
Table 89. SeaSpine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. SeaSpine Sales Value Proportion by Product in 2024
Table 91. SeaSpine Sales Value Proportion by Application in 2024
Table 92. SeaSpine Sales Value Proportion by Geographic Area in 2024
Table 93. SeaSpine Fibrous Demineralized Bone Matrix (DBM) SWOT Analysis
Table 94. SeaSpine Recent Developments
Table 95. Wright Medical Corporation Information
Table 96. Wright Medical Description and Major Businesses
Table 97. Wright Medical Product Models, Descriptions and Specifications
Table 98. Wright Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Wright Medical Recent Developments
Table 100. Straumann Corporation Information
Table 101. Straumann Description and Major Businesses
Table 102. Straumann Product Models, Descriptions and Specifications
Table 103. Straumann Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Straumann Recent Developments
Table 105. Xtant Medical Corporation Information
Table 106. Xtant Medical Description and Major Businesses
Table 107. Xtant Medical Product Models, Descriptions and Specifications
Table 108. Xtant Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Xtant Medical Recent Developments
Table 110. Hans Biomed Corporation Information
Table 111. Hans Biomed Description and Major Businesses
Table 112. Hans Biomed Product Models, Descriptions and Specifications
Table 113. Hans Biomed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Hans Biomed Recent Developments
Table 115. Arthrex Corporation Information
Table 116. Arthrex Description and Major Businesses
Table 117. Arthrex Product Models, Descriptions and Specifications
Table 118. Arthrex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Arthrex Recent Developments
Table 120. VIVEX Biologics Corporation Information
Table 121. VIVEX Biologics Description and Major Businesses
Table 122. VIVEX Biologics Product Models, Descriptions and Specifications
Table 123. VIVEX Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. VIVEX Biologics Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Fibrous Demineralized Bone Matrix (DBM) Product Picture
Figure 2. Global Fibrous Demineralized Bone Matrix (DBM) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Gel Product Picture
Figure 4. Putty Product Picture
Figure 5. Others Product Picture
Figure 6. Global Fibrous Demineralized Bone Matrix (DBM) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Dental Surgery
Figure 8. Spine Surgery
Figure 9. Trauma Surgery
Figure 10. Fibrous Demineralized Bone Matrix (DBM) Report Years Considered
Figure 11. Global Fibrous Demineralized Bone Matrix (DBM) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 13. Global Fibrous Demineralized Bone Matrix (DBM) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Fibrous Demineralized Bone Matrix (DBM) Revenue Market Share by Region (2020-2031)
Figure 15. Global Fibrous Demineralized Bone Matrix (DBM) Sales (2020-2031) & (K Units)
Figure 16. Global Fibrous Demineralized Bone Matrix (DBM) Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Fibrous Demineralized Bone Matrix (DBM) Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Fibrous Demineralized Bone Matrix (DBM) Sales Volume Market Share in 2024
Figure 19. Global Fibrous Demineralized Bone Matrix (DBM) Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Gel Revenue Market Share by Manufacturer in 2024
Figure 22. Putty Revenue Market Share by Manufacturer in 2024
Figure 23. Others Revenue Market Share by Manufacturer in 2024
Figure 24. Global Fibrous Demineralized Bone Matrix (DBM) Sales Market Share by Type (2020-2031)
Figure 25. Global Fibrous Demineralized Bone Matrix (DBM) Revenue Market Share by Type (2020-2031)
Figure 26. Global Fibrous Demineralized Bone Matrix (DBM) Sales Market Share by Application (2020-2031)
Figure 27. Global Fibrous Demineralized Bone Matrix (DBM) Revenue Market Share by Application (2020-2031)
Figure 28. North America Fibrous Demineralized Bone Matrix (DBM) Sales YoY (2020-2031) & (K Units)
Figure 29. North America Fibrous Demineralized Bone Matrix (DBM) Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) in 2024
Figure 31. North America Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Fibrous Demineralized Bone Matrix (DBM) Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Fibrous Demineralized Bone Matrix (DBM) Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) in 2024
Figure 41. Europe Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 46. France Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 61. India Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Fibrous Demineralized Bone Matrix (DBM) Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Fibrous Demineralized Bone Matrix (DBM) Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Fibrous Demineralized Bone Matrix (DBM) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Fibrous Demineralized Bone Matrix (DBM) Revenue (2020-2025) & (US$ Million)
Figure 82. Fibrous Demineralized Bone Matrix (DBM) Industry Chain Mapping
Figure 83. Regional Fibrous Demineralized Bone Matrix (DBM) Manufacturing Base Distribution (%)
Figure 84. Global Fibrous Demineralized Bone Matrix (DBM) Production Market Share by Region (2020-2031)
Figure 85. Fibrous Demineralized Bone Matrix (DBM) Production Process
Figure 86. Regional Fibrous Demineralized Bone Matrix (DBM) Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Wireless Split Keyboard Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Ergonomic Adjustable Computer Chair Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Trackless Keyboard Tray Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232